Poly Medicure Unaudited Financial Results for Q2 FY26
Poly Medicure announced its unaudited financial results for the second quarter of FY26. Consolidated revenue grew by 5.7%, with domestic…
Poly Medicure Board Approves Q2 Results; Pendra Care Acquisition Finalized
Poly Medicure’s board approved the unaudited financial results for Q2, ending September 30, 2025. Standalone revenue reached ₹41,654.17…
Poly Medicure Board Approves Unaudited Financial Results for Q2 & H1 2026
The Board of Directors at Poly Medicure has approved the unaudited financial results for the second quarter and first half of fiscal year…
Apollo Hospitals Approvals Received for Employee Stock Option Plan
Apollo Hospitals Enterprise Limited has received in-principle approval from the Bombay Stock Exchange (BSE) and the National Stock Exchange…
Home First AUM Climbs 26.3% Y-o-Y, Digital Adoption Strengthens
Home First Finance Company India Limited reported a 26.3% year-over-year increase in Assets Under Management (AUM), reaching ₹14,178 crores.…
SKF India Board Meeting Scheduled for November 14, 2025 to Approve Unaudited Financial Results
SKF India has announced a board meeting scheduled for November 14, 2025, to consider and approve the unaudited financial results for the…
Craftsman Automation Board Approves Unaudited Financial Results for Q2 2026
Craftsman Automation’s Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and…
Craftsman Automation Reports Unaudited Financial Results for Q2 2026
Craftsman Automation has released its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from…
Ramkrishna Forgings Board to Consider Fundraising and Quarterly Results
Ramkrishna Forgings has announced a board meeting scheduled for November 12, 2025, to consider and approve the unaudited standalone and…
Lupin Bioresearch Center Receives Zero FDA Observations
Lupin Limited announced its Bioresearch Center in Pune received zero observations from the U.S. Food and Drug Administration (FDA) following a…